{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T05:03:25Z","timestamp":1785301405592,"version":"3.55.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early-stage triple-negative breast cancer is predominantly managed with multidisciplinary perioperative treatment strategies. However, the optimal therapeutic approach for elderly patients who are unsuitable for surgical resection and unable to tolerate systemic chemotherapy remains to be fully elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report the case of a patient diagnosed with triple-negative breast cancer who, following multidisciplinary team (MDT) evaluation, was considered unsuitable for surgical resection and unable to tolerate systemic chemotherapy. A locoregional treatment strategy was adopted. The patient received transarterial infusion chemotherapy with docetaxel (60 mg) and cisplatin (60 mg), followed two weeks later by ultrasound-guided microwave ablation of the breast lesion. Given the aggressive biological characteristics of triple-negative breast cancer, the large tumor size, and the use of local treatment, adjuvant local radiotherapy combined with oral capecitabine was administered for 6 months. Breast ultrasonography performed 3 months later demonstrated a marked reduction in lesion size (2.9 \u00d7 1.5\u00a0cm). After more than 3 years of follow-up, the patient maintained a partial response according to RECIST version 1.1 criteria, with the residual lesion measuring 2.4\u00a0cm and exhibiting well-defined margins.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case provides a potential alternative therapeutic option for patients with triple-negative breast cancer who are unsuitable for surgery and unable to tolerate systemic chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1874496","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:44:00Z","timestamp":1785300240000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Transarterial infusion chemotherapy combined with microwave ablation for inoperable triple-negative breast cancer: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Yang","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhezhu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haosen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology Center, The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songnan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Yanbian University (Yanbian Hospital)","place":["Yanji, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: Pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040819","article-title":"Early triple negative breast cancer: Conventional treatment and emerging therapeutic landscapes","volume":"12","author":"Diana","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000498","article-title":"Adjuvant and neoadjuvant treatment of triple-negative breast cancer with chemotherapy","volume":"27","author":"Marra","year":"2021","journal-title":"Cancer J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_390464","article-title":"Early-stage triple-negative breast cancer journey: Beginning, end, and everything in between","volume":"43","author":"Han","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.546883","article-title":"Microwave ablation versus nipple sparing mastectomy for breast cancer \u22645 cm: A pilot cohort study","volume":"10","author":"Yu","year":"2020","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1739817","article-title":"Neoadjuvant TACE combined with chemo-immunotherapy for giant triple-negative breast cancer: A case report","volume":"17","author":"Tan","year":"2026","journal-title":"Front Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-018-1464-9","article-title":"Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone","volume":"43","author":"Smolock","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-099510","article-title":"Hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitors versus lenvatinib plus PD-1 inhibitors as first-line treatment for hepatocellular carcinoma with high tumour burden and portal vein tumour thrombus (CHANCE 2416): Study protocol of a multicentre, retrospective, target trial emulation design","volume":"15","author":"Liu","year":"2025","journal-title":"BMJ Open"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-11973-8","article-title":"Outcomes following microwave ablation of 669 primary and metastatic lung Malignancies","volume":"36","author":"Geevarghese","year":"2026","journal-title":"Eur Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1088265","article-title":"Latest evidence of microwave ablation for papillary thyroid microcarcinoma compared with surgery: A systematic review and meta-analysis","volume":"13","author":"Feng","year":"2023","journal-title":"Front Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S409011","article-title":"Clinical results, risk factors, and future directions of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma","volume":"10","author":"Dong","year":"2023","journal-title":"J Hepatocell Carcinoma"},{"key":"B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.medj.2024.01.015","article-title":"Preoperative single-dose camrelizumab and\/or microwave ablation in women with early-stage breast cancer: A window-of-opportunity trial","volume":"5","author":"Pan","year":"2024","journal-title":"Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2023.2186325","article-title":"Microwave ablation without subsequent lumpectomy versus breast-conserving surgery for early breast cancer: A propensity score matching study","volume":"40","author":"Dai","year":"2023","journal-title":"Int J Hyperthermia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1038\/s41598-024-56642-w","article-title":"Discussing the safety and effectiveness of transcatheter arterial embolization combined with intravenous chemotherapy in treating locally advanced breast cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2023.12.016","article-title":"Feasibility study\u00a0of\u00a0transarterial chemotherapy followed by chemoembolization for recurrent\u00a0breast cancer","volume":"35","author":"Hori","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.breast.2017.09.001","article-title":"Transarterial chemoembolisation for breast cancer with liver metastasis: A systematic review","volume":"36","author":"Wang","year":"2017","journal-title":"Breast"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.31679","article-title":"Intrahepatic arterial infusion of chemotherapy: Pharmacologic principles","volume":"29","author":"Ensminger","year":"2002","journal-title":"Semin Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s40262-019-00740-w","article-title":"Clinical pharmacokinetics and pharmacodynamics of transarterial chemoembolization and targeted therapies in hepatocellular carcinoma","volume":"58","author":"Hulin","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002343","article-title":"Effect of arterial infusion of bleomycin on esophageal carcinoma--an evaluation by nuclear cytophotometry","volume":"13","author":"Maruta","year":"1983","journal-title":"Jpn J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002343","article-title":"Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12967-017-1124-9","article-title":"Microwave ablation combined with\u00a0OK-432 induces Th1-type response and specific antitumor immunity in a murine\u00a0model of breast cancer","volume":"15","author":"Li","year":"2017","journal-title":"J Transl Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2015.1137639","article-title":"Doxorubicin hydrochloric increases tumour coagulation and end-point survival in percutaneous microwave ablation of tumours in a VX2 rabbit tumour model","volume":"32","author":"Song","year":"2016","journal-title":"Int J Hyperthermia"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1874496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:44:13Z","timestamp":1785300253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1874496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":25,"alternative-id":["10.3389\/fonc.2026.1874496"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1874496","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1874496"}}